NGN Capital

edit

NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector. The fund focuses specifically on investments in the healthcare, pharmaceutical, and biotech sectors including drug products, medical devices, diagnostics, and healthcare services.

Milestones

edit

• 
  NGN Capital invested in BeneChill. (9/15/09)
  Posted 9/18/09 at 6:42am
• 
  NGN Capital invested in Small Bones Innovations. (7/20/09)
  Posted 7/20/09 at 11:40am
• 
  NGN Capital invested in Small Bones Innovations. (5/10/09)
  Posted 6/23/09 at 12:28pm
• 
  NGN Capital invested in Aerovance. (4/7/09)
  Posted 4/10/09 at 8:36am
• 
  NGN Capital invested in Cerapedics. (4/2/09)
  Posted 4/13/09 at 12:57pm
• 
  NGN Capital invested in ACT Biotech. (5/6/08)
  Posted 6/6/09 at 6:27am
• 
  NGN Capital invested in Aerovance. (3/28/07)
  Posted 6/19/09 at 10:47am

Investments

Videos

Sources

1. BeneChill, Inc.: Series C $13.5M (onbiovc.com) [edit]
2. Small Bone Innovations, Inc.: Series D $35M (onbiovc.com) [edit]
3. Small Bone Innovations, Inc: Series D $73M (onbiovc.com) [edit]
4. Aerovance inhales $38M for asthma drugs (venturebeat.com) [edit]
5. CeraPedics, Inc. Raises $15 Million (devicespace.com) [edit]
6. Capital Funding Report [edit]
7. Aerovance, asthma treatment company, finishes raising $60M (deals.venturebeat.com) [edit]